News from the FDA/CDC
FDA/CDC
FDA wants data on role of flavored tobacco products in youth initiation
“Youth consistently report product flavoring as a leading reason for using tobacco products,” FDA Commissioner Gottlieb noted.
FDA/CDC
Lurasidone approved for bipolar I depression for children aged 10-17
The approval is based on results of a 6-week, randomized phase 3 study of 347 children and adolescents.
FDA/CDC
Opioid deaths in the ED increase nationally
Opioid overdose deaths have reached an all-time high across the country.
News from the FDA/CDC
Psychiatric issues common among hepatitis C inpatients
Comorbidities like drug abuse and psychoses present much more often in those with hepatitis C.
News from the FDA/CDC
Drugs identified after suicide deaths
Tests for antidepressants and alcohol were the most likely to be positive.
News from the FDA/CDC
Women filling more ADHD prescriptions
Increase in possible medication exposure during pregnancy “is of public health concern.”
News from the FDA/CDC
Office visits have a chronic problem
Adult visits are more often for long term problems, but pediatric visits tend to be for acute conditions.
News from the FDA/CDC
Developmental disabilities up significantly since 2014
Autism spectrum disorder was almost three times as prevalent in boys as in girls in 2014-2016.
FDA/CDC
New buprenorphine formulation approved for medication-assisted treatment
Patients who are currently taking other buprenorphine formulations can be transitioned.
FDA/CDC
FDA clears first-ever neurostimulation device for opioid withdrawal symptoms
In one study, almost 90% of patients transitioned to medication-assisted treatment after 5 days of using the device.
Latest News
Adherence boon, or Big Brother loom?
Take our poll on the first drug approved in the United States with a digital ingestion tracking system.